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Skin  is  a  rich  source  of proteolytic  enzymes  (1)  and  the  release  of these 
proteinases  may  produce  serious  structural  damage.  Incubation  of skin  with 
commercial preparations  of pancreatic  trypsin and elastase, and bacterial colla- 
genase, produced separation of the epidermis from the dermis (2-6). Indeed, a 
solution of 0.25% bovine pancreatic trypsin is routinely used to separate viable 
epidermis  from  dermis  for  tissue  culture  purposes.  Skin  does  not  encounter 
active  pancreatic  proteinases  in  vivo,  but  there  are  several  neutral  cellular 
endoproteinases that can be found in the skin at reasonable concentrations which 
could act upon the tissue. One of these is a chymotrypsin-like proteinase isolated 
from human  dermis where it appears to be a  mast cell constituent (7-8).  Two 
other neutral  serine proteinases,  cathepsin G  and  elastase,  located in the cyto- 
plasmic  granules  of human  polymorphonuclear  leukocytes, are  also of patho- 
physiological interest (9-12),  since polymorphonuclear leukocytes may migrate 
into the skin in response to inflammatory  signals.  Cathepsin  G  exhibits chymo- 
trypsin-like substrate specificity, but it is distinct from the human  skin chymo- 
trypsin-like proteinase (8). 
This study investigates the effect of human skin chymotrypsin-like proteinase, 
cathepsin  G, and elastase on the integrity of whole skin.  As will be shown, the 
primary  action  of all  three  proteinases  is  at  the  epidermal-dermal  junction. 
Structural alterations in this region were examined by electron microscopy while 
the degradation  of specific proteins was determined by immunohistochemistry 
using  antibodies  to  several  different  basement  membrane  components.  The 
concentrations of proteinase used for our studies were in the range of 10-700 
nM; these enzyme concentrations were selected to approach those that might be 
attained under physiologic or pathologic conditions in skin. They are 100-1,000- 
fold lower than proteinase concentrations used in previous studies. The protein- 
ases used for these studies are highly purified. Also presented is a procedure for 
the simultaneous purification of cathepsin G and elastase from the same human 
leukocyte preparation. 
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Materials and Methods 
Materials.  Protein  standards,  synthetic  substrates,  phenylmethylsuifonyl  fluoride 
(PMSF),  bovine pancreatic  trypsin  (type III),  and  Trasylol (lyophilized powder)  were 
obtained from Sigma Chemical Co., St. Louis, MO. Cyanogen bromide (CNBr)-activated 
Sepharose 4B and  Sephadex G-100 were purchased  from Pharmacia Fine Chemicals, 
Piscataway, N  J. CM-52 cellulose was obtained from Whatman Laboratory Products, Inc., 
Clifton,  NJ,  Brij  and  diisopropylfluorophosphate (DFP) t  from Aldrich  Chemical  Co., 
Milwaukee, WI, and [1,3  ~4C]DFP from New England Nuclear, Boston, MA (120 mCi/ 
mmol). 
Enzymatic Assays.  During purification, cathepsin G was primarily monitored by follow- 
ing the hydrolysis of 0.1  mM N-benzoyl-DL-phenylalanine-/3-naphthyl ester at pH 7.6 (1, 
3). Elastase  was monitored by following the hydrolysis of 0.25 mM N-succinyl-L-alanyl-L- 
alanyl-alanine p-nitroanilide under the conditions of Nakajima et al. (14). 
Estimation  of Proteinase Concentration.  The concentrations of the human skin chymo- 
trypsin-like proteinase and cathepsin G were determined using their specific activities for 
N-benzoyl-L-tyrosine  ethyl ester (8). Under the assay conditions used (a solution of 0.3 M 
Tris-HCl (pH 8.0),  1.5 M KCI,  15% ethanol, 0.5 mM substrate), the specific activities of 
the human skin chymotrypsin-like proteinase and cathepsin G were 7.7 and 1.3 U/nmol 
enzyme, respectively. The concentration of elastase was calculated from kinetic data for 
the hydrolysis of N-succinyl-L-alanyl-L-alanyl-alanine  p-nitroanilide according to the rela- 
tionship: [El = Vmax/kcat, where [El is the enzyme concentration. Vmax was experimentally 
determined from Lineweaver-Burk plots. The kcat value, 2.l/s, and the assay conditions 
were those reported by Nakajima et al.  (14).  In one preparation the concentration of 
elastase was verified by radioactively labeling the purified proteinase with [1,3 ~4C]DFP 
and quantitating bound radioactivity. The value obtained was within 10% of that obtained 
using kinetic data. Trypsin concentration was determined using its extinction coefficient 
of 14.3 (280 nm  1% solution,  1 cm pathlength) reported in the Worthington Enzyme 
Manual (Worthington Biochemical Corporation, Freehold, NJ, 1972, p. 125). 
Purification  of Proteinases.  (a) Human skin chymotrypsin-like proteinase: The purifi- 
cation method was that of Schechter et al. (8). Proteinase was precipitated from the high 
salt extract of human skin by the addition of 0.025% protamine chloride and was then 
chromatographed on a Sephacryl S-200 column and a CH-Sepharose-D-tryptophan methyl 
ester affinity column. The proteinase was between 30 and 50% pure at this stage and was 
not contaminated with other proteolytic enzymes. The concentration of this proteinase in 
human skin is 200 nM. This value is higher than previously reported. 
(b) Human leukocyte elastase and cathepsin G: The purification scheme was developed 
from the previously reported methods of Schmidt and  Havemann (9) and  Baugh and 
Travis (10).  400 ml of heparinized blood was separated into leukocyte and erythrocyte 
fractions by differential sedimentation in a solution containing 3% (wt/vol) dextran T- 
500 and 0.15 M NaCI.  Leukocytes were concentrated from the supernatant by centrif- 
ugation (2,000 rpm for 10 min in a Sorvall GS-3 rotor; Sorvall Instruments Div., DuPont 
Co., Wilmington, DE) and contaminating erythrocytes were removed by three cycles of 
hypotonic lysis. The resulting leukocyte pellets were usually stored at -20 °C until needed. 
Proteinases were solubilized by the suspension of cell pellets in 8 ml of a cold, high-sah 
detergent solution (1.0 M NaCI, 10 mM sodium phosphate, 1 mM EDTA, and 0.1% Brij) 
followed by sonication (4  x  15 s with microprobe at setting 4  on a  Branson Sonifier; 
Branson Sonic Power Co., Danbury, CT). The suspension was clarified by centrifugation 
(20,000 rpm for 0.5 h with an SS-34 rotor at 4°C) and the supernatant fractionated by 
chromatography on a Sephadex G-100 column (100 x  2.3 cm bed volume) equilibrated 
at 4°C with the high-sah detergent buffer. Elastase  eluted at ~300 ml while cathepsin G 
eluted at ~340 ml. The elastase- and cathepsin G-containing fractions were both dialyzed 
against a solution of 5.0 mM MES [2-(N-morpholino)-ethanesulfonic acid] (pH 5.7), 0.15 
l Abbreviations used in this paper:  DFP,  diisopropylfluorophosphate; ELISA, enzyme-linked im- 
munosorbent assay; FITC, fluorescein isothiocyanate; HBSS, Hanks' balanced salt solution; MES, 2- 
(N-morpholino)-ethanesulfonic  acid; PBS, phosphate-buffered saline; PMSF, phenylmethylsulfonyl 
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M  NaCI in preparation for ion exchange chromatography on a  10  ml CM-52 cellulose 
column (see Fig. 1). Specifically the proteinases were eluted with a 300 ml linear gradient 
of NaCI (containing MES buffer) ranging from 0.15 to 1.5 M NaCI. Eiastase and cathepsin 
G obtained from ion exchange columns were then purified to virtual homogeneity using 
a Trasylol-Sepharose 4B affinity column (2.5  ml swollen resin) prepared as described in 
the Pharmacia Fine Chemicals handbook. The separate pools of elastase and cathepsin G 
from CM-52 chromatography were adjusted to pH 8.0 by the addition of 1.0 M Tris-HCl 
(pH 8.0) and layered onto the affinity columns. The columns were then washed with 25 
ml of a 0.05 M Tris-HCl (pH 8.0), 0.4 M NaC! solution and the proteinases were eluted 
with a solution of 0.05  M sodium acetate (pH 5.0),  0.4  M  NaC1. The total recovery of 
both  proteinases  by  this  purification  method  was  ~25%,  and  the  amount  of enzyme 
purified from 400  ml blood was 2.1  nmol cathepsin G  and 7.5  nmol elastase. Purified 
elastase preparations did not hydrolyze N-benzoyl-L-tyrosine ethyl ester (0.7 mM substrate 
for 20 min), a substrate of cathepsin G, and cathepsin G preparations did not hydrolyze 
the elastase substrate. 
(c) Trypsin:  Purification of trypsin was accomplished using a  Trasyiol-Sepharose 4B 
column prepared as described above. Trypsin dissolved in phosphate-buffered saline (PBS) 
was bound  to the resin.  The column was then  eluted with  0.2  M  acetic acid  (pH 3.2) 
followed by 0.2 M HCI. The HCI solution eluted trypsin that was not contaminated with 
chymotrypsin. Trypsin preparations were quickly dialyzed in Hanks' balanced salt solution 
(HBSS) as described subsequently. 
Radioactive DFP Labeling.  In  separate  experiments,  elastase  (0.4  ml  of a  2.6  t~M 
solution) and cathepsin G (0.4 ml of a 0.6 ~M solution) were incubated with 0.05 ml of 
2.0  M  Tris-HCl (pH  8.3)  and  10  ~C of [1,3  14C]DFP  (120  mCi/mmol; New  England 
Nuclear) at 37°C for 1.5 h. The reaction was stopped by the addition of 0.5 ml unlabeled 
0.1  M DFP in propylene glycol and unbound DFP was removed by dialysis. 
Sodium Dodecyl Sulfate (SDS) Polyacrylamide Slab Gel Electrophoresis.  SDS gel electro- 
phoresis was performed as described by Anderson et al. (15) using a running gel composed 
of  17.5%  acrylamide and  0.8%  bisacrylamide.  Proteinase  samples were  denatured  by 
heating  to  100°C  for  10  min in  a  solution  of 0.5%  SDS  and  2%  2-mercaptoethanol. 
Diluted samples were concentrated by lyophilization. Proteins used for calibration were 
phosphorylase b (100,000  mol wt),  bovine serum albumin  (67,000),  catalase (60,000), 
ovalbumin (43,000), carbonic anhydrase (30,000), soybean trypsin inhibitor (21,500), and 
lysozyme (14,000).  To visualize bands, gels were either stained with Coomassie Brillant 
Blue or dried  in  the presence of Autofluor (National  Diagnostics Inc., Somerville, NJ) 
and fluorographed on Kodak XAR-5 x ray film at -70°C. 
Preparation of Proteinases  for Incubation with Skin.  Proteinases were dialyzed against 
sterile HBSS (minus indicator) containing  15  mM Hepes (pH 7.5) and 0.35 g/l sodium 
bicarbonate. Enzyme concentrations for incubations were determined by standard assay 
procedures after dialysis.  For control studies, comparable concentrations of proteinases 
were inhibited before dialysis with 2.0 mM PMSF or DFP.  Inactivation of enzymes was 
>99% complete. Skin specimens were placed directly into 1.0 ml of enzyme solutions. 
Human Skin Preparation and Enzyme Incubation.  Skin was removed from the  upper 
thigh or buttocks of normal healthy human volunteers after obtaining informed consent. 
The skin area was prepared with Betadine and alcohol, and anesthetized with xylocaine. 
Thin, split-thickness strips of skin were removed with a Castroviejo dermatotome set to 
cut  at  a  depth  of 0.4  mm.  The  skin  strips  were  placed  in  cold  buffer  (HBSS)  and 
immediately transported  to the  laboratory where  the  strips were further  divided  into 
pieces approximately 1.0-1.5 mm wide and 4-5 mm long. Histologic monitoring indicated 
that the skin thickness of the specimens varied from a dermal thickness equivalent to that 
of the epidermis to a dermal thickness twice that of the epidermis. 
The time from skin removal to initiation of enzyme incubation did not exceed 30 rain 
in any experiment. The skin specimens were placed in Linbro plate wells,  three to four 
pieces per well, containing  1 ml active enzyme solution, inhibited enzyme solution,  or 
buffer control and incubated in a humidified incubator at 36°C for varying times from 2 
to 8 h before samples were removed. After incubation, the treated skin specimens were 1030  DEGRADATION  OF  THE  EPIDERMAL-DERMAL JUNCTION 
washed with buffer and immediately prepared for transmission electron microscopy or 
embedded in  OCT compound (Ames  Laboratories, Inc.,  Milford, CT) and  frozen in 
liquid nitrogen for immunocytochemical studies. 
Specimens  for  electron  microscopy were  fixed  in  2.5%  glutaraldehyde  in  0.2  M 
phosphate buffer, pH 7.4, for 4 h, washed, postfixed in  1% osmium tetroxide solution 
for 1 h, embedded in Epon resin 812, and then cut with diamond knives. After staining 
with uranyl acetate and Reynold's lead citrate, the specimens were visualized in either a 
JEM T7 orJEM 100B electron microscope (JEOL Ltd., Tokyo). 
Immunohistochemical Studies.  Antibodies with reactivity to components of human skin 
basement membrane zone were used for immunohistochemical studies. Bullous pemphi- 
goid antibody was obtained from two patients with classical  bullous pemphigoid; titers 
against  human  skin as substrate  were  1:160 and  1:320.  The specificity of the bullous 
pemphigoid antibody was confirmed by immunoelectron microscopy which localized the 
antibody to the lamina lucida. Rabbit antilaminin (Engelbreth-Holm Swarm [EHS] tumor 
derived) antibody was obtained from Bethesda Research Laboratories, Gaithersburg, MD. 
The specificity of this antibody was documented by enzyme-linked immunosorbent assays 
(ELISA) and immunoprecipitation with laminin (specific antibody concentration of ~0.25 
/~g/ml). Rabbit anti-type IV collagen (EHS tumor derived) antibody was a gift from Dr. 
David Woodley (Department of Dermatology, University of North Carolina School of 
Medicine,  Chapel  Hill,  NC).  The  specificity of this  antibody was  documented by  its 
reactivity  with  type  IV  collagen  in  an  ELISA  (data  not  shown).  The  antibody  was 
unreactive to iaminin, heparan sulphate proteoglycan, and fibronectin. Another rabbit 
anti-type IV procollagen antibody (bovine lens capsule derived) was a gift of Dr. Nicholas 
Kefalides (Department of Connective Tissue Research, University of Pennsylvania, Phil- 
adelphia, PA). Mouse monoclonal antibodies (AF 1 and AF2) to anchoring fibrils of human 
skin (16,  17) were used in a working dilution of 1:10 and  1:20 (titers of the antibodies 
were  1:40).  Mouse monocional antibody (KF1) with demonstrated reactivity to human 
skin lamina densa (18) was  a  gift of Dr.  Stephen Katz (National  Institutes of Health, 
Bethesda,  MD) and  was  used  in  a  dilution  of  1:20  (titer of this antibody was  1:80). 
Acquired epidermolysis builosa antibody obtained from two patients with acquired epi- 
dermolysis builosa was shown by immunoelectron microscopy to react with antigen in the 
sub-lamina densa zone and to a limited extent in the lamina densa. Working dilutions of 
these antibodies were 1:20, 1:40 (titer of both was 1:160). 
Working dilutions of the above antibodies were determined by chessboard titration 
with the appropriate fluoresceinated antibody conjugate and a series of working dilutions 
selected  in  the  mid-zone  of reactivity.  Fluorescein  isothiocyanate (FITC)-conjugated 
antibody with specificities for rabbit, human, and mouse immunoglobulin were used in 
dilutions determined by chessboard titration above. 
Indirect immunofluorescence was performed according to Beutner and Nisengard (19). 
4-6-#m-thick sections of skin were cut and air dried on glass slides.  Sections were then 
incubated for 30 min in a humid chamber at 25°C with appropriate dilutions of each of 
the specific antisera described above. Sections were then washed twice for  10-15 min 
each  in  PBS;  moisture  was  removed and  the  slides  were  incubated  for  30  min  in 
appropriate  FITC-conjugated antisera,  twice  rinsed  again  in  PBS,  and  coverslipped. 
Specimens were examined in a Leitz Orthoplan microscope equipped with epiiilumination 
and the following filter systems for fluorescence microscopy (exciter filter EP 450-490, 
barrier filter LP 515, and beam splitter PKP 510; E. Leitz, Inc., Rockleigh, NJ). Results 
were recorded photographically using Kodak Ektachrome 400 film. 
Results 
Purification of Proteinases.  Human skin chymotrypsin-like proteinase was pu- 
rified as described by Schechter et al.  (8).  Human  leukocyte cathepsin  G  and 
elastase  were  purified  by a  method  developed  from  two  previously reported 
procedures (see Materials and  Methods);  this is an  improvement over previous 
methods because it results in the purification of each proteinase from the same BRIGGAMAN  ET  AL.  1031 
blood  preparation  and  avoids  steps  that  may  result  in  the  precipitation  of 
cathepsin G (9,  10). The method involves (a) solubilization of both proteinases 
in a high-salt detergent solution, (b) gel filtration chromatography in the same 
solution to separate cathepsin G from elastase, (c) ion exchange chromatography 
to complete the separation (Fig. 1), and (d) affinity chromatography on a Trasylol- 
Sepharose 4B resin. Purified cathepsin G (G) and elastase (E) preparation analyzed 
by SDS polyacrylamide gel electrophoresis are presented in Fig. 2. Fig. 2a is a 
photograph of a  gel with the resolved polypeptide chains stained Coomasie 
Brillant Blue and Fig.  2 b is a  fluorogram of the proteinases inactivated with 
radioactive DFP  before analysis.  The banding patterns  obtained show some 
evidence of microheterogeneity. Both leukocyte proteinases are recognized as a 
family ofisoenzymes  differing  in carbohydrate content (9, 10). The low molecular 
weight (<10,000) polypeptides in the fluorogram of cathepsin G  may be the 
result of slight autodegradation during the incubation with radioactive label. 
Ultrastructural Studies.  Since these proteinases primarily affect the epidermal- 
dermal junction, it is appropriate to orient the reader to this well-characterized 
structure (20,  21).  Ultrastructurally,  the junction between basal  keratinocytes 
and the dermis, proceeding from the epidermis to the dermis, consists of the 
basal cell plasma membrane studded along its length with hemidesmosomes; an 
electron lucent  zone beneath the cell  membrane, termed the lamina lucida 
(lamina rara), which is crossed by fine "anchoring" filaments; an electron dense 
layer, the lamina densa (basal  lamina) and  a  fibrous  zone (sub-lamina  densa 
fibrous zone or reticular (lamina) beneath the lamina densa composed of three 
fibrous elements: anchoring fibrils,  dermal microfibril bundles, and collagen 
fibers.  The adepidermal ends of the anchoring fibrils  and dermal microfibril 
bundles insert directly into the lamina densa. Anchoring fibrils have a character- 
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FIGURE  l.  CM-52 cellulose chromatography of cathepsin  G and elastase after their initial 
separation  by gel filtration chromatography.  Left graph depicts the fractionation pattern of 
the elastase preparation and the right graph  depicts  the  fractionation of the cathepsin  G 
preparation. Absorbance  at 410 nm (closed circles) marks the hydrolysis of N-succinyl-L-alanyl- 
L-alanyl-alanine p-nitroanilide, a substrate preferred by elastase, and absorbance at 520 nm 
(open circles) marks the hydrolysis of N-benzoyl-DL-phenylalanine-~/-napthyl  ester, a substrate 
preferred by cathepsin G. Solid line indicates the NaCI gradient. E, NaCI concentration (0.25 
M) where  the elastase peak elutes; G, NaCI concentration (0.55  M) where  the cathepsin  G 
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FIOORE 2.  SDS polyacrylamide gel electrophoresis of purified cathepsin G (G) and elastase 
(E) preparations.  (a) Polypeptide chains stained with Coomassie Brilliant Blue and (b) fluoro- 
gram of proteinases inactivated with radioactive DFP before analysis. Lane G-I is an analysis 
of cathepsin G purified by the method of Schmidt and Havemann (9) and tracks G-2 and G 
are analyses of cathepsin  G purified  by the  method  presented  here.  Elastase preparations 
analyzed were purified  by the method described  here.  2.5 #g of cathepsin G and  10.0 t~g 
elastase were analyzed in a and 3.5 #g of radioactive cathepsin G and 2.0 #g of radioactive 
elastase were analyzed in b. X ray film was allowed to develop for 48 h and the migration of 
standards is indicated by their molecular weights (see Materials and Methods). 
istic central cross-banded portion and a  fan-like arrangement of filament toward 
the  ends.  Dermal  microfibril  bundles  are  composed  of  parallel  bundles  of 
microfibrils,  morphologically  identical  with  elastic  microfibrils  of true  elastic 
tissue.  Indeed,  these  dermal  microfibrii  bundles  course  perpendicularly  deep 
into the dermis where actual connections to elastic fibers have been found (22). 
Collagen  fibers are present  in  the sub-lamina densa region,  but do not connect 
directly with either the lamina densa or with the other sub-lamina densa fibrous 
structures. 
All  degradation  studies  were  monitored  as  a  function  of time  and  enzyme 
concentration.  Incubations  of skin  with  proteinases  were  for periods of 2-8  h, 
and they were performed at two different proteinase concentrations,  designated 
high  and  low.  For the  human  skin  chymotrypsin-like proteinase  and  cathepsin 
G,  the  high  concentrations  ranged  between  70  and  100  nM  and  the  low 
concentrations ranged between  10 and 25 nM.  For elastase, the high concentra- 
tion ranged between 600 and 700 nM and the low concentration ranged between 
100  and  200  nM.  The  morphological  changes  produced  by  the  human  skin 
chymotrypsin-like proteinase  and  elastase  were  studied  in  five separate  experi- BRIGGAMAN ET  AL.  1033 
ments,  whereas those produced by cathepsin  G  were studied in three separate 
experiments. The major degradative changes produced by each proteinase were 
highly reproducible. All studies were performed in parallel with controls consist- 
ing  of incubations  containing  proteinases  inhibited  by PMSF and  incubations 
with buffer along. 
Human Skin Chymotrypsin-like  Proteinase.  The degradation  of the epidermal- 
dermal junction  by the  human  skin  chymotrypsin-like  proteinase  is  shown  in 
Figs. 3 and 4. The earliest changes were evident after 4-6 h of incubation with 
proteinase  at  high  concentration.  The  initial  changes  included clearing  in  the 
lamina iucida and loss of the anchoring filaments that normally traverse this area 
(Fig. 3). Irregular widening along the length of the lamina lucida was also evident 
as well as focal areas of frank epidermal-dermal  separation (Fig. 4). By 6-8 h of 
incubation,  extensive  epidermal-dermal  separation  was observed.  Degradation 
appeared largely confined to the lamina  lucida;  the lamina densa and the sub- 
lamina densa fibrillar  network remained  intact.  At lower proteinase concentra- 
tions, the same pattern of damage is observed, but the alterations are delayed by 
2-4 h.  The dependence of morphological alterations on enzyme concentration 
and time suggests that changes are a direct result of degradation by the protein- 
ase. Limited morphological changes were seen in the epidermis, especially in skin 
treated with high enzyme concentrations for 6-8 h. These alterations consisted 
FIGURE 3.  Normal human skin incubated with active human skin chymotrypsin-like  protein- 
ase (concentration, 100 nm/ml; 36°C) for 4 h. Loss  of structure and widening of the lamina 
lucida (LL) are present. Lamina densa (LD) and anchoring fibrils (AF) are intact. X 87,000. 
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FIGURE 4.  Normal human skin incubated with active human skin chymotrypsin-like  protein- 
ase (concentration, 100 nM/ml; 36°C) for 6 h. Focal epidermal-dermal separation (arrow) is 
evident at the level of the lamina lucida (LL). X 90,000. Bar = 0.5 #m. 
primarily  of focal disruptions  along the basal cell plasma membrane and occa. 
sional  disruptions  in  the  membranes  of the  lower  spinous  cells.  Some  lateral 
separation  of cells  in  the  lower  portion  of the  epidermis  was  also  observed. 
Dermal alterations were not detected in these studies. 
Human Leukocyte Cathepsin  G.  The earliest morphological changes observed 
with cathepsin  G were those seen at 8 h  incubation with high concentrations of 
proteinase.  The  pattern  of alterations  was  qualitatively  similar  to  the  initial 
alterations observed with the human skin chymotrypsin-like proteinase; i.e., focal 
areas of epidermal-dermal  separation. 
Human Leukocyte Elastase.  The earliest changes noted for elastase were after 
2  h  of incubation  at high  proteinase concentrations.  The most striking change 
evident was a  decrease in the  density of the lamina  densa.  As the  incubations 
continued (Fig. 5), the lamina densa began to disappear and regions of epidermal- 
dermal separation were seen. By 6 h  the lamina densa was completely absent in 
all preparations (Fig. 6). Similar results were observed in incubations containing 
lower elastase concentrations, except that the time required for degradation was 
longer. No epidermal alterations were noted. 
Although  lamina  densa  was  extensively  destroyed,  anchoring  fibrils  were 
apparently  not affected directly.  Morphologically  intact  anchoring  fibrils were 
observed in the upper dermis subjacent to intact basal cell plasma cell membranes 
(Figs.  5, 6). Many of these anchoring fibrils retained their characteristic  central 
banding  pattern.  Anchoring  fibrils  were  seen  singly,  in  small  clusters  and  in BRIGGAMAN  ET  AL.  1035 
FIGURE 5.  Normal human skin treated with active leukocyte elastase for 4 h (concentration, 
600 nM/ml, 36°C). Focal absence of lamina densa and epidermal-dermal separation (arrow) 
is seen in a portion of the junction zone. Residual lamina densa (LD)  is present in the adjacent 
junction. Anchoring fibrils (/iF) and collagen fibers (C) appear structurally intact, x  67,000. 
Bar =  0.5 ~m. 
dense aggregates. Their orientation was haphazard, probably resulting from loss 
of attachment  to  the  lamina  densa.  Overall,  the  number of anchoring  fibrils 
appeared  to be similar to the skin in the inhibited enzyme and buffer-treated 
controls. 
Microfibril bundles that also attach to the lamina densa were similarly altered 
(data  not shown).  Individual  microfibrils appeared  to  remain  intact,  but they 
were no longer grouped as bundles. Rather, they appeared as individual fibrils 
or small groups of scattered fibrils. Dermal collagen fibers were morphologically 
unaltered  by  elastase  as  evidenced  by  the  similarity  of  their  appearance  to 
controls.  Interestingly,  the  lamina  densa  of dermal  blood vessels was also  de- 
stroyed by elastase.  Damage to dermal blood vessels was not observed for the 
chymotrypsin-like proteinases. 
Trypsin.  Because the damage to the epidermal-dermal junction by the chy- 
motrypsin-like proteinases  and elastase  was  markedly different,  we believed it 
important to determine the type of damage to skin that might be produced by 
proteinases having trypsin-like specificity. To accomplish this, the degradation 
of skin by commercial pancreatic bovine trypsin purified by affinity chromatog- 
raphy (see Materials and Methods) was monitored. The studies were performed 
at  100  and  25  nM  proteinase.  By  4  h  of incubation  with  100  nM  trypsin, 
extensive epidermal-dermal separation had occurred. Epidermal-dermal separa- 1036  DEGRADATION OF THE  EPIDERMAL-DERMAL  JUNCTION 
FIGURE 6.  Normal human skin treated with active leukocyte  elastase for 6 h (concentration, 
600 nm/ml; 36°C). Complete absence of lamina densa is evident at the epidermal-dermal 
junction. Anchoring fibrils (AF) and collagen fibers (C) appear structurally intact, x 54,000. 
Bar  =  0.5  urn. 
tion  was also apparent,  but to a  lesser extent,  with  the  lower concentration  of 
trypsin.  The alterations  observed are qualitatively similar  to that seen with the 
chymotrypsin-like proteinases,  although  they were more extensive at the same 
time period. 
Immunohistochemical  Studies.  Antibodies  to  known  junctional  components 
were used to define the specific epidermal-dermal junction constituents affected 
by each proteinase and to further describe the level at which epidermal-dermal 
separation  was occurring.  The  bullous pemphigoid  and  antilaminin  antibodies 
define antigenic components in the lamina lucida (23-26). Anti-type IV collagen 
antibodies and the KF 1 monoclonal antibody define antigens in the lamina densa 
(18,  27,).  EBA,  AF1,  and  AF2  antibodies  localize  antigens  in  the  sub-lamina 
densa fibrous zone (16,  17, 28-30). 
Skin incubated with the high concentrations of the human skin chymotrypsin- 
like  proteinase  did  not  show  differences  in  immunofluorescent  staining  until 
epidermal-dermal  separation  had occurred (that is,  in incubations of 6  and 8  h 
with high proteinase concentrations).  In separated regions, bullous pemphigoid 
antibody localized to the epidermal side of the separation  plane in a  somewhat 
discontinuous pattern on the basal cell surface (Fig. 7, a and b), whereas laminin 
(Fig.  7,  c and  d) and  all  the  other  antigens  localized  to  the  dermal  side.  The 
intensity of all immunofluorescent staining (even at serial antibody dilutions) in 
separated skin remained comparable to controls and did not diminish with time, 
suggesting  there  is no significant  degradation  of these antigens  by the  human 
skin chymotrypsin-like proteinase. Since bullous pemphigoid antigen and laminin BRIGGAMAN  ET  AL.  1037 
FIGURE 7.  Distribution of antibodies to specific basement membrane components in normal 
human skin treated for 6  h  with active human  skin chymotrypsin-like proteinase (B, D) and 
inhibited enzyme (A, C). A and B show localization of bullous pemphigoid antibody. In active 
enzyme-treated  skin,  bullous  pemphigoid  antibody  localizes to  the  epidermal  side  of the 
epidermal-dermal separation (arrow). C and D show antilaminin antibody localization. In active 
enzyme-treated skin, antibody  staining is seen on the dermal  side of the epidermal-dermal 
separation (arrow). 
TABLE  I 
Human Leukocyte Elastase (4 h Incubation, High Concentration) 
Antibody to:  Inhibited  Active 
Bullous pemphigoid  +  Linear BMZ  +  On epidermal side of separation 
Laminin  +  Linear BMZ and vascular BM  Absent 
Type IV collagen  +  Linear BMZ and vascular BM  Absent 
KF1  +  Linear BMZ  Absent 
EBA antigen  +  Linear BMZ  Absent 
AF1, AF2  +  Linear BMZ  +  Scattered on dermal side of separa- 
tion 
BMZ, basement membrane zone; EBA, epidermolysis bullosa acquisita. KF-1 is a monoclonal antibody 
that recognizes an antigen in the lamina densa (18).  AF1 and AF2 are monoclonal antibodies specific 
for anchoring fibrils (16,  17). 
are major components of the lamina lucida, these results correlate well with the 
ultrastructurai  observations  showing  that  the  human  skin  chymotrypsin-like 
proteinase  produces  epidermal-dermal separation  in  a  plane  confined  to  the 
lamina lucida. 
In skin treated with human leukocyte elastase, alterations in antibody localiza- 
tion were observed by 4 h incubation with active enzyme when epidermal-dermal 
separation  was evident in  most samples.  As expected from the  ultrastructural 
studies, the changes in antibody distribution and appearance were more extensive 
than observed with the human skin chymotrypsin-like proteinase. These changes 
are  described  in  Table  I.  No  immunofluorescent staining  was  observed  for 1038  DEGRADATION  OF  THE  EPIDERMAL-DERMAL JUNCTION 
laminin, type  IV  collagen (Fig.  8,  a  and  b),  KF1  antigen, and  EBA antigen, 
indicating profound  dissolution  of the  lamina lucida and  lamina densa.  The 
bullous pemphigoid antigen was clearly present, and again localized in a some- 
what discontinuous pattern on the epidermal side of the separation plane. The 
intensity of its staining is comparable to controls and remains constant in longer 
incubations,  suggesting  that  bullous  pemphigoid antigen  is  not  degraded by 
elastase.  Immunofluorescent staining was also observed with the anchoring fibril 
antibodies, AF1  and AF2, on the dermal side of the separation plane (Fig. 8, c 
and  d).  The  staining,  however, was  not  uniformly linear as  in  the  controls. 
Instead, there was significant speckling and scattering along the staining band, 
which probably reflects the disorganized pattern observed for anchoring fibrils 
in the ultrastructural studies. 
Discussion 
Freshly obtained human skin was degraded with relatively low concentrations 
(20-700 nM) of proteinases having chymotryptic, elastolytic, and tryptic specific- 
ities. The proteinases with chymotryptic and elastolytic specificities were isolated 
from human leukocytes and human skin, and the proteinase with tryptic specific- 
ity was purified from bovine pancreatic trypsin. In all cases the primary degra- 
dation observed was at the epidermal-dermal junction, and the ultimate result 
was epidermal-dermal separation. These studies clearly show that the epidermal- 
dermal junction is highly susceptible to proteolytic damage. Although all pro- 
FIGURE 8.  Distribution of antibodies to specific basement membrane components in normal 
human  skin treated  for 4  h  with active leukocyte elastase (B, D) and elastase inhibited with 
phenylmethylsulfonyl fluoride (A, C). a  and B show antibody type IV procollagen antibody 
localization. Absence of antibody staining is seen in active elastase-treated skin (B). C and D 
show  localization of monoclonal antibodies  to  anchoring  fibrils (AFI  and  AF2).  Antibody 
staining  is seen  in active elastase-treated  skin  on  the  dermal  side  of the epidermal-dermal 
separation (arrow). BRIGGAMAN  ET  AL.  1039 
teinases altered the epidermal-dermal junction, the extent and type of degrada- 
tion were proteinase specific. 
The human skin chymotrypsin-like proteinase and cathepsin G, both protein- 
ases with chymotrypsin-like specificity, degrade the epidermal-dermal junction 
in the lamina lucida,  producing epidermal-dermal separation and little other 
apparent morphological damage. Long incubations (6-8 h) with the human skin 
chymotrypsin-like proteinase resulted in extensive epidermal-dermal separation 
while similar incubations with high concentrations of cathepsin G only resulted 
in focal damage. The junctional proteins degraded by the human skin chymo- 
trypsin-like proteinase were not identified by immunofluorescent staining using 
antisera to a variety of basement membrane proteins, including laminin and type 
IV collagen. After epidermal-dermal separation, however, laminin localized on 
the dermal side of the split while the bullous pemphigoid antigen remained on 
the epidermal side, still apparently associated with an intact basal cell membrane. 
The intensity of staining of both these antigens and their persistence in incuba- 
tions of long duration and high proteinase concentration suggest they were not 
the direct targets of proteolytic hydrolysis. Laminin is a high molecular weight 
protein that is believed to span the lamina lucida and to mediate the attachment 
of epithelial cells to type IV collagen (31). In view of this, the protein(s) degraded 
by the human skin chymotrypsin-like proteinase and cathepsin G may be those 
that  help  provide  a  linkage  between  laminin and  the  basal  cell  membrane. 
Terranova et al.  (32)  has  recently characterized  such a  protein from human 
breast carcinoma cells. 
The degradation of isolated basement membrane proteins with proteinases of 
chymotrypsin-like specificity has  been  reported.  Rao  et  al.  (33)  showed that 
isolated  laminin  is  readily  degraded  by  bovine  pancreatic  chymotrypsin and 
cathepsin G.  The  immunohistochemical studies presented here  indicate  that 
laminin in its native environment is not highly susceptible to either cathepsin G 
or  the  human  skin  chymotrypsin-like proteinase,  even  though  the  plane  of 
epidermal-dermal separation was in the lamina lucida.  It has also been shown 
(34-36)  that a  chymotrypsin-like proteinase isolated from rat peritoneal mast 
cells,  rat mast cell proteinase I, is capable of partially degrading isolated Type 
IV and V collagen. The human skin chymotrypsin-like proteinase, which may be 
the human analogue to this proteinase, did not appear to degrade basement 
membrane collagen; the lamina densa remained intact even after 8-h incubations, 
and the presence of type IV collagen was documented by immunofluorescence. 
This suggests that there may be significant differences in the proteolytic suscep- 
tibility  of isolated  basement  membrane proteins as  compared with  the  same 
proteins in their native environments. 
Of the proteinases characterized, human leukocyte elastase produced the most 
widespread damage to the epidermal-dermal  junction. Degradation of the lamina 
densa is consistent with the in vitro studies demonstrating that type IV and V 
collagens are good substrates for elastases of leukocyte or pancreatic origin (37, 
38).  Elastase digestion also resulted in the disappearance of laminin, the KF1 
antigen, and the EBA antigen. Whether these proteins are removed by direct 
degradation or they are released because of the dissolution of type IV collagen 
cannot be determined from our studies. The only epidermal-dermal components 1040  DEGRADATION  OF THE  EPIDERMAL-DERMAL  JUNCTION 
that persisted after elastase digestion are the bullous pemphigoid antigen, micro- 
filament bundles, anchoring fibrils, and collagen fibers. Although microfilament 
bundles and anchoring fibrils remain, they appear scattered and disoriented, as 
a result of the loss of their attachment sites to the lamina densa. The extensive 
degradation  of the epidermal-dermal junction  by  elastase  is  significant for it 
demonstrates that human  leukocyte elastase alone is capable of dissolving the 
epidermal-dermal  junction. 
The proteinases  used for these studies were isolated  from human skin and 
from human ieukocytes. Conditions may exist where all or some of these enzymes 
are released into the skin. The concentration of the human skin chymotrypsin- 
like proteinase in skin is ~200 nM, which is above the lowest concentration used 
to produce epidermal-dermal separation.  The distinctive degradation patterns 
described here could help to implicate and identify these or similar proteinases 
as mediators in skin diseases where degradation of the epidermal-dermal  junction 
occurs. 
Summary 
The degradation of normal human  skin  by  the human polymorphonuclear 
leukocyte proteinases cathepsin G and elastase, and by a human skin chymotryp- 
sin-like proteinase  that  appears  to  be  a  mast  cell  constituent,  was  examined. 
Enzymes were incubated with fresh, split-thickness skin for up to 8 h; the tissue 
was examined ultrastructurally and immunohistochemically using antibodies to 
known  basement  membrane  constituents.  In  all  cases,  the  primary  damage 
observed was at  the epidermal-dermal junction.  Elastase degraded the lamina 
densa leaving scattered and disorganized anchoring fibrils,  dermal microfibril 
bundles, and normal-appearing collagen fibers. Immunohistochemically, type IV 
collagen,  laminin,  KF1  antigen,  and  EBA  antigen  were absent.  The  bullous 
pemphigoid antigen was present and localized on the basal cells. 
Epidermal-dermal separation produced by the chymotrypsin-like proteinases, 
cathepsin G, and the human skin proteinase, was confined to the lamina lucida. 
The lamina densa and sub-lamina densa fibrillar network remained intact. The 
human skin chymotrypsin-like proteinase produced extensive epidermal-dermal 
separation, while cathepsin G, at comparable concentrations, produced only focal 
separations. Immunohistochemically, all antigens were present after incubation 
with  enzyme. The  bullous  pemphigoid  antigen,  however,  was  found  on  the 
epidermal side of the split, while laminin was found on the dermal side. 
These results show that the epidermal-dermal junction is highly susceptible to 
neutral serine proteinases located in  mast cells and polymorphonuclear leuko- 
cytes. Although all  the proteinases produce epidermal-dermal separation,  the 
patterns and  extent of degradation  are different. The  distinctive patterns  of 
degradation may provide a clue to the involvement of these proteinases in skin 
diseases. 
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